Physician
Integrated Regional Laboratories Pathology Services, LLC
Integrated Regional Laboratories Pathology Services, LLC was paid $301K by Medicaid between Feb 2021 and Dec 2024, across 75 billing codes. Its largest line is 87276, — 26% of everything it billed.
33Billing provider infoINTEGRATED REGIONAL LABORATORIES PATHOLOGY SERVICES, LLC
LOXAHATCHEE, FL 33470
LOXAHATCHEE, FL 33470
33aNPI1265007603assigned 05/26/2021
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$301K
24GClaims143,072
24DCodes billed75
24AFirst – last monthFeb 2021 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#40 of 207
Median peer was paid$39K
This provider vs. median7.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RODKEY, JOHN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 9,223 | $19K | |
| 2022 | 25,081 | $61K | |
| 2023 | 61,739 | $173K | |
| 2024incomplete | 47,029 | $48K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87276 | 26% | 7,372 | 7,075 | $78K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.5% | 3,853 | 3,644 | $29K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 6.7% | 256 | 238 | $20K |
| 80053 | Comprehensive metabolic panel | 6.0% | 8,937 | 5,780 | $18K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 5.9% | 840 | 779 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.4% | 11,424 | 6,257 | $16K |
| 87040 | 4.1% | 3,953 | 3,411 | $12K | |
| 85027 | 3.9% | 22,197 | 11,818 | $12K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.9% | 662 | 602 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.6% | 3,782 | 3,649 | $8K |
| 81025 | 2.3% | 4,692 | 4,287 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.1% | 155 | 143 | $6K |
63 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 110 | $6K |
| 84702 | 1.5% | 1,022 | $4K | |
| 84484 | 1.4% | 2,996 | $4K | |
| 85060 | 1.3% | 236 | $4K | |
| 87088 | 1.1% | 3,414 | $3K | |
| 82805 | 1.0% | 205 | $3K | |
| 82803 | <1% | 220 | $3K | |
| 83605 | <1% | 1,907 | $2K | |
| 87077 | <1% | 1,182 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 577 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 703 | $2K |
| 88307 | <1% | 38 | $2K | |
| 80076 | <1% | 4,820 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 307 | $2K |
| 83735 | <1% | 2,473 | $2K | |
| 85730 | <1% | 4,174 | $2K | |
| 86850 | <1% | 3,325 | $2K | |
| 87070 | <1% | 3,612 | $1K | |
| 81001 | <1% | 5,652 | $1K | |
| 86140 | <1% | 3,727 | $1K | |
| 86880 | <1% | 722 | $1K | |
| 87807 | <1% | 2,298 | $1K | |
| 82247 | <1% | 1,350 | $1K | |
| 83690 | <1% | 3,094 | $1K | |
| 86900 | <1% | 4,269 | $1K | |
| 83880 | <1% | 381 | $971.54 | |
| 85610 | <1% | 4,415 | $891.21 | |
| 86901 | <1% | 4,849 | $864.15 | |
| 80329 | <1% | 174 | $635.58 | |
| 81003 | <1% | 3,305 | $611.61 | |
| 80320 | <1% | 213 | $556.22 | |
| 87075 | <1% | 151 | $486.57 | |
| 82550 | <1% | 422 | $444.56 | |
| 80061 | Lipid panel | <1% | 137 | $431.35 |
| 87205 | <1% | 756 | $430.44 | |
| 82728 | <1% | 270 | $403.97 | |
| 84100 | <1% | 1,254 | $398.91 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 70 | $377.27 |
| 87186 | <1% | 228 | $367.86 | |
| 84703 | <1% | 194 | $326.47 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 84 | $275.01 |
| 87045 | <1% | 196 | $269.98 | |
| 85652 | <1% | 963 | $219.36 | |
| 85014 | <1% | 965 | $200.82 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 260 | $161.32 |
| 85379 | <1% | 358 | $150.42 | |
| 85045 | <1% | 653 | $142.55 | |
| 87340 | <1% | 144 | $92.12 | |
| 86762 | <1% | 44 | $81.58 | |
| 85018 | <1% | 959 | $80.93 | |
| 83540 | <1% | 238 | $76.97 | |
| 83550 | <1% | 102 | $59.28 | |
| 84439 | <1% | 72 | $55.65 | |
| 84157 | <1% | 243 | $47.17 | |
| 84550 | <1% | 158 | $34.17 | |
| 82570 | <1% | 48 | $23.85 | |
| 85049 | <1% | 43 | $20.87 | |
| 82607 | <1% | 13 | $7.32 | |
| 84132 | <1% | 69 | $6.64 | |
| 87210 | <1% | 13 | $5.60 | |
| 80179 | <1% | 15 | $2.24 | |
| 82272 | <1% | 41 | $2.08 | |
| 86308 | <1% | 16 | $1.62 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRODKEY, JOHN (OWNER/VP OF OPERATIONS)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.